期刊文献+

子宫颈腺癌中ILK与E-Cadherin蛋白表达的关系

Relationship of ILK Expression with E-Cadherin in Cervical Adenocarcinoma
下载PDF
导出
摘要 目的探讨子宫颈腺癌组织中整合素连接激酶(ILK)与E-Cadherin的表达关系。方法采用免疫组织化学方法检测106例子宫颈腺癌组织中和22例慢性子宫颈炎组织中ILK与E-Cadherin的表达。结果106例子宫颈腺癌组织ILK的阳性表达率为86.8%,高于慢性子宫颈炎组织(P<0.01);E-Cadherin蛋白表达率为58.5%,低于慢性子宫颈炎组织81.8%(P<0.05)。ILK在子宫颈腺癌病理分级,G3组阳性表达率均明显高于G1组(P<0.05)。E-Cadherin表达与子宫颈腺癌组织类型有关,透明细胞腺癌阳性表达率低于子宫颈内膜腺癌和子宫内膜样腺癌(P<0.05)。ILK阳性表达强度与E-Cadherin的阳性表达强度呈负相关(P<0.05)。结论ILK与E-Cadherin在子宫颈腺癌组织中的表达密切相关,E-Cadherin低表达与ILK增强表达在子宫颈腺癌的发生发展中起重要作用,三者可能作为子宫颈腺癌恶性化的分子标志。 Objective To study the relationship of the expression of ILK with E-Cadherin in cervical adenocarcinoma.Methods The expression of ILK with E-Cadherin was determined by immunohistochemistry in 106 cases of cervical adenocarcinoma and 22 cases of cervical chronic inflammation.Results The positive rates of ILK in cervical adenocarcinoma were 86.8%,which were higher than that in cervical chronic inflammation(P0.01).The positive rates of E-Cadherin in cervical adenocarcinoma was 58.5%,which was lower than that in cervical chronic inflammation(P0.05).The positive of ILK was significantly higher in G3 than i G1 adenocarcinoma(P0.05).The expression of E-Cadherin was related to the histologic types,the level of E-Cadherin was lower in clear-cell adenocarcinoma than others(P0.05).There was negative correlation between the expression of ILK and ECadherin(P0.05).Conclusion Low-expression of E-Cadherin and over-expression of ILK are closely related in cervical adenocarcinoma and they play an important role in the development of cervical adenocarcinoma.The two biomarkers might be the indicators for the transformation of cervical lesions from benign to malignant status.
出处 《中外医疗》 2010年第7期34-36,共3页 China & Foreign Medical Treatment
关键词 子宫颈肿瘤 腺癌 ILK E-CADHERIN 免疫组织化学 Cervical neoplasm Adenoma ILK E-Cadherin Immunohistochemistry
  • 相关文献

二级参考文献30

  • 1Yang XY, Jiang SOL Zhang L, Liu QN, Gong PL. Inhibitory effect of dauricine on inflammatory process following focal cerebral ischemia/reperfusion in rats. AmJ Chin Med 2007; 35: 477-86.
  • 2Su YM, Zhang C, Xiao JY, Gang HL, Wang ZG, Hua D. Effects of PAMD on the proliferation of human tumor cells of PC-3 and BT5637. Harbin Yi Ke Da Xue Xue Ba 2007; 41: 129-31. Chinese.
  • 3Al-Harris ES, Al-Janabi AA, Al-Toriahi KM, Yasseen AA. Over expression of vascular endothelial growth factor in correlation to Ki-67, grade, and stage of breast cancer. Saudi Med J 2008; 29: 1099-104.
  • 4Applanat ME Buteau-Lozano H, Herve MA, Corpet A. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression. Adv Exp Med Bio12008; 617: 437-44.
  • 5Slomiany MG, Rosenzweig SA. Hypoxia-inducible factor- dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther 2006; 318: 666-75.
  • 6Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O, et al. Hypoxia-inducible factor-lalpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I. Clin Cancer Res 2006; 12: 4506-14.
  • 7Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ. Topotecan blocks hypoxia-inducible factor-lalpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells. Cancer Res 2005; 65: 4775-81.
  • 8Cao Z, Fang J, Xia C, Shi X, Jiang BH. trans-3,4,5'-Trihydroxy- stibene inhibits hypoxia-inducible factor lalpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004; 10: 5253-63.
  • 9Kondo S, Seo SY, Yoshizaki T, Wakisaka N, Furukawa M, Joab I, et al. EBV latent membrane protein i up-regulates hypoxia-inducible factor lalpha through Siahl-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res 2006; 66: 9870-7.
  • 10Tang X, Zhang Q, Nishitani J, Brown J, Shi SH, Le AD. Over- expression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor lalpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res 2007; 13: 2568-76.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部